LPAR4 inhibition has been demonstrated to decrease the experimental atherosclerosis elicited by adeno-associated virus expressing gain-of-function allele of the PCSK9 D377Y mutation in rats fed a fat-rich diet [15]. This evidence concerns the gene LPAR4 and atherosclerosis.